MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 113 filers reported holding MAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,718 | -30.0% | 250,000 | 0.0% | 0.19% | -15.0% |
| Q2 2023 | $1,111,775 | -7.6% | 250,000 | 0.0% | 0.23% | -12.1% |
| Q1 2023 | $1,202,663 | -9.1% | 250,000 | 0.0% | 0.26% | -10.8% |
| Q4 2022 | $1,323,328 | -18.2% | 250,000 | 0.0% | 0.29% | -14.8% |
| Q3 2022 | $1,618,000 | +39.8% | 250,000 | 0.0% | 0.34% | +41.4% |
| Q2 2022 | $1,157,000 | -34.4% | 250,000 | 0.0% | 0.24% | -23.6% |
| Q1 2022 | $1,764,000 | -30.5% | 250,000 | 0.0% | 0.31% | -21.0% |
| Q4 2021 | $2,538,000 | -16.2% | 250,000 | 0.0% | 0.40% | -19.5% |
| Q3 2021 | $3,027,000 | – | 250,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |